YZD-27
/ Xi'an Qin Shen Jia He Pharmaceutical Research
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
January 31, 2026
A Randomized, Open-label, Placebo-controlled, Multiple-dose Phase I Clinical Study Evaluating the Safety, Tolerability, and Pharmacokinetics of YZD-27 for Injection in Healthy Subjects
(ChiCTR)
- P1 | N=10 | Not yet recruiting | Sponsor: The Third Xiangya Hospital of Central South University; Third Xiangya Hospital, Central South University
New P1 trial • Cardiovascular • Ischemic stroke
1 to 1
Of
1
Go to page
1